Osteoblast differentiation is orchestrated by a complex interplay of signalling cascades, among which the Mitogen-Activated Protein Kinase (MAPK) pathways play a central role. MAPKs, including the ...

A recent study indicates that inhibiting TGF-β may enhance the efficacy of anti-sclerostin-based osteoporosis treatment by reactivating quiescent osteoblasts. In a bone-loss mouse model, combining TGF ...

Researchers found that mice lacking membrane ERα signaling in osteoblast lineage cells had significantly lower cortical bone mass, highlighting the pathway’s critical role in maintaining the strength ...

Osteoporosis is a common disorder, especially in the elderly, characterized by bone loss and increased fracture risk. Treatments target abnormal osteoclast activity but face adherence issues. The ...

Osteoporosis, a common skeletal disorder, is marked by reduced bone mass and deterioration of bone microarchitecture, making bones more porous and prone to fractures. Bone health is maintained through ...

A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...

Stringent Full-Chain QC & Reproducible Cell Performance of CloudClone Win Recognition from Top Labs in Germany and the ...